DHR

Danaher Corporation [DHR] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

DHR Stock Summary

Top 10 Correlated ETFs

DHR


Top 10 Correlated Stocks

DHR


In the News

05:26 30 Nov 2023 DHR

Danaher Corporation: A Good Contrarian Bet

Danaher Corporation is facing near-term headwinds due to COVID-19-related demand normalization and customer inventory destocking in its Biotechnology segment. However, these headwinds are temporary, and the company's medium to long-term growth story is attractive. The company has a healthy balance sheet, strong exposure to high-growth end markets like Biologics, and a history of driving shareholder value through portfolio transformation and strategic M&A.

02:36 30 Nov 2023 DHR

Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles

Danaher focuses on innovation for steady, high-value recurring revenue, driving financial stability. Aging population, longer lifespans, and tech advances drive Danaher's sector toward significant growth. I expect a 10% revenue dip from lowered COVID-19 product sales, with recovery projected in 12 months.

01:13 30 Nov 2023 DHR

3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape

The U.S. continues to spend more money on healthcare than any other country. Healthcare spending totaled $4.3 trillion, according to the American Medical Association.

04:15 30 Nov 2023 DHR

Danaher to Present at Evercore ISI HealthCONx Conference

WASHINGTON , Nov. 21, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conference in Miami, Florida on Wednesday, November 29, 2023 at 3:00 p.m.

07:16 30 Nov 2023 DHR

Last Call: 3 Growth Stocks to Buy Before New Year's Eve

In the shifting sands of the current stock market, discerning investors continue to navigate a labyrinth of uncertainties. Yet, the allure of long-term growth stocks remains undiminished.

11:03 30 Nov 2023 DHR

Three value stock picks from a veteran manager with a good performance record

For many years through 2022, it was becoming more difficult for active fund managers to make the case for their services, when broad index funds, with lower fees, were performing so well. But the tech-driven market decline for 2022 might have made some investors think again about different investment styles for the long term.

05:30 30 Nov 2023 DHR

A New Bull Market Is Coming! 3 Stocks Set to Soar 65% to 132% Higher

Regardless of whether you're a Wall Street veteran or new to investing, the past four years have been a roller coaster ride. A global pandemic brought a 14-year-long bull market to a screeching halt.

02:21 30 Nov 2023 DHR

Make Me a Millionaire: 3 Top Growth Stocks to Buy Now

The stock market is on the downswing. Many traders are dumping their holdings as inflation, interest rates, and geopolitical crises weigh heavily on sentiment.

01:32 30 Nov 2023 DHR

Danaher's (DHR) Q3 Earnings & Revenues Beat, Decline Y/Y

While Danaher (DHR) surpasses Q3 earnings and revenue estimates, the company's performance is hurt by a decrease in the sale of COVID-related products and weak demand in the Life Sciences segment.

12:44 30 Nov 2023 DHR

Danaher 3Q earnings beat but shares fall on disappointing outlook

Danaher (NYSE:DHR)'s third quarter earnings topped Wall Street estimates on the top and bottom lines but its weak guidance saw investors retreat from the stock.   The company - which designs, manufactures and markets products and services across a range of industries including medical and industrial – reported a 10.5% year-over-year drop in revenue to $6.9 billion.

DHR Financial details

Company Rating
Strong Buy
Market Cap
163.61B
Income
5.92B
Revenue
29.57B
Book val./share
70.88
Cash/share
16.6
Dividend
1.06
Dividend %
0.48%
Employees
79K
Optionable
No
Shortable
Yes
Earnings
22 Jan 2024
P/E
27.34
Forward P/E
33.21
PEG
-31.97
P/S
5.47
P/B
3.09
P/C
13.43
P/FCF
23.86
Quick Ratio
1.76
Current Ratio
2.26
Debt / Equity
0.42
LT Debt / Equity
0.37
-
-
EPS (TTM)
8.02
EPS next Y
6.71
EPS next Q
2.21
EPS this Y
11.74%
EPS next Y
-16.34%
EPS next 5Y
-1.84%
EPS last 5Y
20.99%
Revenue last 5Y
9.61%
Revenue Q/Q
-3.97%
EPS Q/Q
2%
-
-
-
-
SMA20
12.95%
SMA50
-2.68%
SMA100
3.81%
Inst Own
52.91%
Inst Trans
0.68%
ROA
7%
ROE
12%
ROC
0.07%
Gross Margin
59%
Oper. Margin
20%
Profit Margin
20%
Payout
14%
Shs Outstand
738.93M
Shs Float
688.56M
-
-
-
-
Target Price
318.19
52W Range
182.09-249.5922
52W High
-10.5%
52W Low
+22.45%
RSI
66
Rel Volume
0.53
Avg Volume
3.18M
Volume
1.69M
Perf Week
5.61%
Perf Month
8.82%
Perf Quarter
6.81%
Perf Half Y
10.66%
-
-
-
-
Beta
0.831
-
-
Volatility
1.66%, 11.11%
Prev Close
1.87%
Price
222.86
Change
1.47%

DHR Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
28.3925.0531.5541.2243.4
Net income per share
3.784.215.1699.94
Operating cash flow per share
5.745.538.7911.711.75
Free cash flow per share
4.914.647.679.8910.16
Cash per share
1.1227.858.553.628.27
Book value per share
40.2742.3456.3163.2169.07
Tangible book value per share
-13.35-3.05-23.97-26.38-13.74
Share holders equity per share
40.2742.3456.3163.2169.07
Interest debt per share
14.1330.5430.4131.3727.43
Market cap
64.05B97.28B139.07B208.43B170.62B
Enterprise value
73B99.1B154.24B228.02B184.3B
P/E ratio
24.1632.3438.1432.423.67
Price to sales ratio
3.225.436.247.085.42
POCF ratio
15.9224.6222.424.9420.03
PFCF ratio
18.6329.3425.6729.5123.16
P/B Ratio
2.273.213.54.613.41
PTB ratio
2.273.213.54.613.41
EV to sales
3.675.536.927.745.86
Enterprise value over EBITDA
15.3421.525.2222.5817.18
EV to operating cash flow
18.1525.0824.8527.2821.63
EV to free cash flow
21.2329.8828.4732.2825.02
Earnings yield
0.040.030.030.030.04
Free cash flow yield
0.050.030.040.030.04
Debt to equity
0.350.720.530.490.39
Debt to assets
0.20.350.280.270.23
Net debt to EBITDA
1.880.392.481.941.28
Current ratio
1.475.191.861.431.89
Interest coverage
21.6330.115.3931.3741.18
Income quality
1.521.621.71.321.18
Dividend Yield
0.010.01000
Payout ratio
0.160.250.170.120.11
Sales general and administrative to revenue
00000
Research and developement to revenue
0.060.060.060.060.06
Intangibles to total assets
0.790.520.740.770.71
Capex to operating cash flow
-0.15-0.16-0.13-0.15-0.14
Capex to revenue
-0.03-0.04-0.04-0.04-0.04
Capex to depreciation
-0.45-0.53-0.45-0.6-0.52
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
58.5563.3180.88113.15124.3
ROIC
0.070.050.060.090.11
Return on tangible assets
0.260.10.190.340.3
Graham Net
-21.76-12.14-37.06-42.77-31.75
Working capital
2.25B20.66B6.4B3.51B7.49B
Tangible asset value
-9.35B-2.18B-16.93B-18.85B-9.96B
Net current asset value
-12.51B-6.2B-22.58B-26.36B-18.38B
Invested capital
0.350.720.530.490.39
Average receivables
3.51B3.34B3.62B4.34B4.77B
Average payables
1.61B1.61B1.78B2.31B2.43B
Average inventory
1.88B1.77B1.96B2.53B2.94B
Days sales outstanding
64.0365.0466.2557.3957.04
Days payables outstanding
71.1669.7376.2481.5366.93
Days of inventory on hand
79.3574.9785.2987.8190.65
Receivables turnover
5.75.615.516.366.4
Payables turnover
5.135.234.794.485.45
Inventory turnover
4.64.874.284.164.03
ROE
0.090.10.090.140.14
Capex per share
-0.83-0.89-1.12-1.81-1.59

Quarterly Fundamentals Overview

Last date of statement is 2023-09-29 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-29
2.02K2.02K2.02K2.02K2.02K
Revenue per share
10.5211.489.839.719.3
Net income per share
2.163.061.991.51.53
Operating cash flow per share
2.763.492.672.612.26
Free cash flow per share
2.383.032.292.151.77
Cash per share
7.078.2210.1211.6316.6
Book value per share
64.568.7170.5870.1470.88
Tangible book value per share
-15.4-13.67-11.44-9.72-7.47
Share holders equity per share
64.568.7170.5870.1470.88
Interest debt per share
26.4827.0827.2827.0529.93
Market cap
166.81B171.51B162.98B156.88B162.63B
Enterprise value
180.91B185.19B175.43B168.18B172.41B
P/E ratio
26.5319.2128.135.4636.01
Price to sales ratio
21.7720.4922.7421.9223.66
POCF ratio
82.9967.583.7181.4597.27
PFCF ratio
96.2677.5497.4798.97124.43
P/B Ratio
3.553.423.173.033.1
PTB ratio
3.553.423.173.033.1
EV to sales
23.6122.1324.4823.525.09
Enterprise value over EBITDA
70.282.0573.07115.2783.21
EV to operating cash flow
9072.8890.187.32103.12
EV to free cash flow
104.3983.72104.92106.1131.92
Earnings yield
0.010.010.010.010.01
Free cash flow yield
0.010.010.010.010.01
Debt to equity
0.410.390.390.380.42
Debt to assets
0.240.230.230.230.25
Net debt to EBITDA
5.476.065.197.754.72
Current ratio
1.781.891.892.082.26
Interest coverage
47.9826.4426.3813.3919.7
Income quality
1.281.141.341.741.48
Dividend Yield
00000
Payout ratio
0.130.090.140.20.18
Sales general and administrative to revenue
00000
Research and developement to revenue
0.050.050.060.060.06
Intangibles to total assets
0.720.710.70.690.66
Capex to operating cash flow
-0.14-0.13-0.14-0.18-0.22
Capex to revenue
-0.04-0.04-0.04-0.05-0.05
Capex to depreciation
-0.51-0.58-0.49-0.61-0.66
Stock based compensation to revenue
0.010.010.010.020.01
Graham number
55.9668.856.1848.6649.35
ROIC
0.020.020.020.010.02
Return on tangible assets
0.070.090.060.040.04
Graham Net
-32.89-31.58-29.13-26.94-24.86
Working capital
6.25B7.49B7.8B9.06B11.84B
Tangible asset value
-11.22B-9.96B-8.35B-7.17B-5.53B
Net current asset value
-19.79B-18.38B-17.02B-15.72B-14.11B
Invested capital
0.410.390.390.380.42
Average receivables
4.47B4.66B4.62B4.26B4.2B
Average payables
2.31B2.24B2.19B2.02B1.93B
Average inventory
3.25B3.17B3.25B3.28B3.1B
Days sales outstanding
51.7852.8954.1652.855.01
Days payables outstanding
64.0460.2466.9656.559.33
Days of inventory on hand
94.5981.6108.8691.9494.73
Receivables turnover
1.741.71.661.71.64
Payables turnover
1.411.491.341.591.52
Inventory turnover
0.951.10.830.980.95
ROE
0.030.040.030.020.02
Capex per share
-0.38-0.45-0.38-0.46-0.49

DHR Frequently Asked Questions

What is Danaher Corporation stock symbol ?

Danaher Corporation is a US stock , located in Washington of Dc and trading under the symbol DHR

Is Danaher Corporation buy or a sell ?

19 stock analysts have 19 predictions with a medium analyst target price of $320.74. The lowest prediction is $265 and the highest is $370

What is DHR stock prediction ?

With a median analyst target price of $300, 1 stock analysts have made 1 forecasts in last 90 days. $300 is the lowest and $300 is the greatest projection.

What is Danaher Corporation stock quote today ?

Danaher Corporation stock price is $222.86 today.

Is Danaher Corporation stock public?

Yes, Danaher Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks